Subscribe: HSMN NewsFeed
Added By: Feedage Forager Feedage Grade B rated
Language: English
devices  healthcare sales  healthcare  marketing network  marketing  network  nov healthcare  nov  sales marketing  sales  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: HSMN NewsFeed

HSMN NewsFeed

Healthcare Sales & Marketing Network NewsFeed

Last Build Date: Sat, 25 Nov 2017 03:52:35 CST


Hologic Receives FDA 510(k) Clearance of Quantra(TM) 2.2 Breast Density Assessment Software

Fri, 24 Nov 2017 14:44:10 GMT

Latest addition to market-leading portfolio of innovative breast and skeletal health solutions to be featured at RSNA 2017 MARLBOROUGH, Mass., Nov. 24, 2017 -- (Healthcare Sales & Marketing Network) -- Hologic, Inc. (Nasdaq: HOLX) announced today that ...
Devices, Radiology, Oncology, FDA
Hologic, Quantra 2.2, Breast Density Assessment, imaging

Phase III study with Amikacin Inhale in intubated and mechanically ventilated patients with Gram-negative pneumonia does not meet primary endpoint of superiority

Fri, 24 Nov 2017 14:36:45 GMT

WHIPPANY, N.J., Nov. 24, 2017 -- (Healthcare Sales & Marketing Network) -- Bayer today announced that INHALE, a global Phase III clinical study program investigating Amikacin Inhale in addition to standard of care in intubated and mechanically ventilated ...
Biopharmaceuticals, Drug Delivery
Bayer, Amikacin Inhale

New Canon Digital Radiography Systems to be Showcased at RSNA Annual Meeting, Highlighting Ergonomic Design

Wed, 22 Nov 2017 15:24:28 GMT

Canon U.S.A. also announces new version of software to streamline workflow for Canon detectors MELVILLE, N.Y., Nov. 22, 2017 -- (Healthcare Sales & Marketing Network) -- Leveraging the rich history of high-quality imaging and innovation of its parent c...
Devices, Radiology, Product Launch
Canon, CXDI, digital radiography

Ampio Announces Publication of Ampion(TM) Treatment of Severe Osteoarthritis of the Knee as a Feature Article in Orthopedics Peer-Reviewed Journal

Wed, 22 Nov 2017 12:58:36 GMT

ENGLEWOOD, Colo., Nov. 22, 2017 -- (Healthcare Sales & Marketing Network) -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that a manuscript entitled: "LMWF-5A for the Treatment of Severe Osteoarthritis of the Knee: Integrated Analysis...
Biopharmaceuticals, Orthopaedic
Ampio Pharmaceuticals, osteoarthritis, Ampion

Mitsubishi Tanabe Pharma America Expands Executive Leadership Team, Names Kevin O'Brien as Vice President of Market Access

Tue, 21 Nov 2017 15:32:02 GMT

JERSEY CITY, N.J., Nov. 21, 2017 -- (Healthcare Sales & Marketing Network) -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the appointment of Kevin O'Brien as Vice President of Market Access and a member of the organization's executive le...
Biopharmaceuticals, Personnel
Mitsubishi Tanabe Pharma

MiMedx Provides Update On Its Reimbursement Coverage

Tue, 21 Nov 2017 15:29:51 GMT

MARIETTA, Ga., Nov. 21, 2017 -- (Healthcare Sales & Marketing Network) -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts ...
Regenerative Medicine, Reimbursement
MiMedx, EpiFix, Venous Leg Ulcer, Diabetic Foot Ulcer

Audentes Therapeutics Announces Publication of Data from RECENSUS, a Retrospective Medical Record Review of Patients With X-Linked Myotubular Myopathy

Tue, 21 Nov 2017 13:05:37 GMT

SAN FRANCISCO, Nov. 21, 2017 -- (Healthcare Sales & Marketing Network) -- Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatenin...
Audentes Therapeutics, X-Linked Myotubular Myopathy, RECENSUS Study

Ardelyx Announces Updated Development Path for its Cardiorenal Pipeline

Tue, 21 Nov 2017 12:58:38 GMT

Company to Host Conference Call at 8:30 a.m. ET Today FREMONT, Calif., Nov. 21, 2017 -- (Healthcare Sales & Marketing Network) -- Ardelyx, Inc. (NASDAQ: ARDX) today provided an update on the development of its cardiorenal pipeline. The company's second...
Ardelyx, tenapanor, hyperphosphatemia

Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda(R) (Lurasidone Hydrochloride) in Europe

Tue, 21 Nov 2017 12:50:34 GMT

TOKYO and ROME, November 21, 2017 -- (Healthcare Sales & Marketing Network) -- Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; President: Masayo Tada; hereinafter "Sumitomo Dainippon Pharma") and Angelini S.p.A. (Head Office: Rom...
Biopharmaceuticals, Licensing, Distribution
Sumitomo Dainippon Pharma, Angelini S.p.A, Latuda, lurasidone

Paradigm Spine, LLC Announces - Highmark, Inc. Is 1st Private Payor To Issue Exclusive Positive Coverage Policy For coflex(R) Interlaminar Stabilization(R) Treatment Of Lumbar Spinal Stenosis

Mon, 20 Nov 2017 15:03:48 GMT

Lumbar Spinal Stenosis Affects 1.6 million U.S. Patients Annually Medical coverage policy issued by Highmark, Inc. and affiliates operating health insurance plans for 5.0 million members in Pennsylvania (PA), West Virginia (WV), and Delaware (DE) Exc...
Devices, Orthopaedic, Neurosurgery, Reimbursement
Paradigm Spine, coflex, Interlaminar Stabilization, Spinal Stenosis

U.S. FDA Approves Kaléo's AUVI-Q(R) (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children

Mon, 20 Nov 2017 14:59:59 GMT

First and only epinephrine auto-injector (EAI) approved with a needle length and dose specifically designed for infants and children weighing 16.5 to 33 pounds (7.5 to 15 kilograms) Anaphylaxis and food allergies increasing in children; previously no EA...
Biopharmaceuticals, Devices, Drug Delivery, FDA
Kaléo, AUVI-Q, Epinephrine, auto-injector

Volpara Receives Regulatory Clearances in Japan and Taiwan

Mon, 20 Nov 2017 14:56:26 GMT

WELLINGTON, New Zealand, Nov. 20, 2017 -- (Healthcare Sales & Marketing Network) -- Volpara Solutions announced today that it has received regulatory clearances for its suite of quantitative breast imaging tools in Japan and Taiwan. In Japan, the full Vol...
Devices, Radiology, Oncology, Regulatory
Volpara Solutions, VolparaDensity, breast imaging

Getinge announces installation of 1,000th Hybrid operating room worldwide

Mon, 20 Nov 2017 13:04:55 GMT

As a pioneer in the design and installation of Hybrid ORs, Getinge is a trusted partner that offers a full range of products for these multi-disciplinary spaces WAYNE, N.J., Nov. 20, 2017 -- (Healthcare Sales & Marketing Network) -- Getinge, a leading ...
Devices, Cardiology, Radiology
Getinge, Hybrid OR

HeartStitch(R) "Sutures The Future" at the TCT in Denver, Colorado

Mon, 20 Nov 2017 12:55:06 GMT

HeartStitch® Showcases its Suture-Based Technologies at US Largest Structural Heart Conference TCT 2017 PROVIDES CLEAR FOCUS ON KEY MARKET SEGMENTS, PFO, MITRAL AND TRICUSPID VALVE STRUCTURAL HEART TREATMENTS FOUNTAIN VALLEY, Calif., Nov. 20, 201...
Devices, Cardiology
Nobles Medical Technology, HeartStitch, NobleStitch

United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)

Mon, 20 Nov 2017 12:45:40 GMT

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2017 -- (Healthcare Sales & Marketing Network) -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivi...
Biopharmaceuticals, FDA, Licensing
United Therapeutics, Adcirca, tadalafil, Duchenne muscular dystrophy